Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma for Severe COVID-19 Patients: a Randomized, Open-label, Phase 3 Trial

NCT04547660 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.

NCT NCT04547660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04547660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma for Severe COVID-19 Patients: a Randomized, Open-label, Phase 3 Trial
Lead sponsor
Hospital de Clinicas de Porto Alegre
Phase
Phase 3
Overall status
Completed
Start date
July 16, 2020
Completion date
January 7, 2021
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19